Profile
Sara Weymer is currently the Director of Clinical Program Management at ZZ Biotech LLC and the Vice President of Clinical Operations at Boundless Bio, Inc. She previously worked as the Executive Director and Head of Clinical Operations at Fate Therapeutics, Inc.
Sara Weymer active positions
Companies | Position | Start |
---|---|---|
BOUNDLESS BIO, INC. | Chief Tech/Sci/R&D Officer | 04/06/2022 |
ZZ Biotech LLC
ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Former positions of Sara Weymer
Companies | Position | End |
---|---|---|
FATE THERAPEUTICS, INC. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
FATE THERAPEUTICS, INC. | Health Technology |
BOUNDLESS BIO, INC. | Health Technology |
Private companies | 1 |
---|---|
ZZ Biotech LLC
ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Sara Weymer